Centauri Therapeutics Limited ('Centauri'), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications, announced today that ...

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...

In a wide-ranging Genomic Press Interview published today in Brain Medicine, Dr. David R. Rubinow recounts the serendipitous ...

Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because ...

If you want to create a perfect storm at Covered California and other Affordable Care Act marketplaces, all you have to do is ...

Gut fungal communities may impact multiple sclerosis severity, offering new insights into MS pathogenesis and potential ...

Boosting greenery may protect against air pollution's impact on dementia, revealing a potential strategy to reduce ...

Urinary incontinence is a devastating condition affecting over 33 million Americans, according to the National Association for Continence, leading to significant adverse impacts on patients' mental ...